PDS Biotechnology Corporation
PARTICULATE VACCINE FORMULATIONS

Last updated:

Abstract:

The present disclosure provides vaccine formulations comprising at least one peptide antigen assembly and at least one adjuvant. The disclosure also provides methods of inducing an immune response in a mammal and methods of treating a disease in a mammal utilizing the vaccine formulations.

Status:
Application
Type:

Utility

Filling date:

21 Mar 2019

Issue date:

12 Sep 2019